Back to Centiva Capital, LP Centiva Capital, LP

TMCI

5 quarters

Position history for Centiva Capital, LPCentiva Capital, LP's holdings in Treace Medical Concepts, Inc.

No. Centiva Capital exited its TMCI (Treace Medical Concepts) position in Q3 2026. Its Q2 2026 13F listed 19,593 shares worth $77,980. Centiva Capital first reported TMCI in Q2 2024 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$179,789

Total Shares Change

-27,036

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Exited
0
-100.0%
$00.0%$4.44
0
2026-Q2
Decreased
19,593
-30.8%
$77,9800.0%$3.98
0
2026-Q1
New
28,311
-
$37,9370.0%$1.34
28
2024-Q3
Exited
0
-100.0%
$00.0%$5.77
0
2024-Q2
New
27,036
-
$179,7890.0%$6.65
31

Other major holders of TMCI: CIBC Private Wealth Group LLC, AllianceBernstein L.P.

Optional analytics helps us improve. How it’s used